Asia Pacific Cell & Gene Research Growing 50% Faster than ROW
Feb 03, 2023 13:00 HKT |  |
|
Ocumension Therapeutics Announces The Completion Of The Phase I Clinical Trial Of Its Class I New Drug For The Treatment Of Dry Eye -- OT-202
Feb 03, 2023 10:01 HKT |  |
|
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China
Feb 01, 2023 10:00 HKT | |
|
Ocumension Therapeutics Appoints Mr. Tim RUAN and Mr. WANG Chong as Chief Financial Officer and Head of Investor Relations respectively
Jan 30, 2023 11:38 HKT | |
|
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
Jan 26, 2023 12:16 HKT |  |
|
EC Healthcare Expects Third Quarter FY23 Sales Volume to Increase no less than 8% YoY
Jan 20, 2023 19:31 HKT |  |
|
BeautyFarm Med, the largest provider of traditional beauty services in China Successfully Listed on the Main Board of SEHK
Jan 17, 2023 14:25 HKT | |
|
BeautyFarm Med Announces Global Offering Results, Offer Price of HK$19.32per Share
Jan 13, 2023 12:10 HKT |  |
|
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Jan 12, 2023 15:00 HKT | |
|
Novotech Acquires European CRO, Strengthens Global Operations
Jan 12, 2023 15:00 HKT | |
|
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)
Jan 11, 2023 21:00 HKT |  |
|
Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program
Jan 11, 2023 15:00 HKT |  |
|
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
Jan 11, 2023 11:19 HKT | |
|
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate
Jan 10, 2023 16:33 HKT |  |
|
Malaysian Genomics Explores R&D Collaboration with SIRIM
Jan 09, 2023 14:00 HKT |  |
|
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
Jan 05, 2023 18:00 HKT | |
|
Sihuan Pharmaceutical (0460.HK): Huisheng Biopharmaceutical Successfully Completes A+ Round of Financing, Accelerating the Layout of Diabetes and Complications
Jan 04, 2023 09:55 HKT |  |
|
Beauty Farm Medical and Health Industry Inc. Announces Proposed Listing on the Main Board of SEHK, Offer price at HK$19.32 per share
Dec 30, 2022 10:18 HKT | |
|
Boan Biotech Announces Global Offering Allotment Results of H Shares
Dec 29, 2022 09:48 HKT |  |
|
Shares of Major Global Medical Device Manufacturer OrbusNeich Medical Group Commence Trading on the Main Board of The Stock Exchange of Hong Kong
Dec 23, 2022 15:10 HKT |  |
|